Newsletters

Newer, More Expensive Post-Angioplasty Drugs May Worsen Disparities

In JAMA Internal Medicine, Elias Dayoub and colleagues found that for patients who underwent angioplasty from 2008-2016, adherence to recommended antiplatelet therapy decreased as newer, more expensive drugs were introduced, particularly among lower-income patients.

The Future of Medicaid: State Legislator Views

In a survey of state legislators, Jane Zhu, Manik Chhabra, and David Grande find a stark partisan divide on certain Medicaid reform proposals, such as work requirements, and common ground on others, such as reducing drug prices. This work was supported by an LDI Policy Accelerator Grant.